Pharmacological modification of thromboxane and prostaglandin release in cardiac anaphylaxis
- 1 May 1978
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 15 (5), 889-900
- https://doi.org/10.1016/0090-6980(78)90156-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Distribution of prostaglandin biosynthetic pathways in several rat tissues. Formation of 6-ketoprostaglandin F1αBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.JCI Insight, 1977
- Limitations Of Prostaglandin AssaysJournal of Investigative Dermatology, 1976
- Coronary Arterial Smooth Muscle Contraction by a Substance Released from Platelets: Evidence That It Is Thromboxane A 2Science, 1976
- Radioimmunoassay for carbenoxoloneJournal of Pharmacy and Pharmacology, 1976
- Release of novel prostaglandins and thromboxanes after immunological challenge of guinea pig lungNature, 1976
- Prostaglandins and cardiac anaphylaxisLife Sciences, 1976
- ISomerization of prostaglandin H2 into prostaglandin D2 in the presence of serum albuminBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human plateletsBiochemical and Biophysical Research Communications, 1976
- Isolation and properties of intermediates in prostaglandin biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973